Astrana Health, Inc.
ASTH
$29.34
$0.1450.50%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -65.45% | -48.94% | -18.90% | -5.88% | 6.96% |
| Total Other Revenue | 32.89% | 25.22% | 20.66% | 22.20% | 27.86% |
| Total Revenue | 29.71% | 22.76% | 19.34% | 21.19% | 27.06% |
| Cost of Revenue | 31.66% | 23.83% | 19.67% | 24.03% | 28.65% |
| Gross Profit | 19.73% | 17.55% | 17.71% | 7.76% | 19.50% |
| SG&A Expenses | 51.80% | 55.96% | 49.74% | 44.97% | 47.62% |
| Depreciation & Amortization | 46.10% | 25.28% | 6.25% | 1.17% | -5.49% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.49% | 26.32% | 21.80% | 25.21% | 29.35% |
| Operating Income | -16.13% | -14.86% | -8.01% | -18.85% | 4.59% |
| Income Before Tax | -15.83% | -7.58% | 7.61% | 3.72% | 84.94% |
| Income Tax Expenses | -38.50% | -43.12% | -21.39% | -21.74% | 42.68% |
| Earnings from Continuing Operations | 0.97% | 25.71% | 33.01% | 26.47% | 137.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 138.96% | 125.11% | 108.79% | 603.16% | -136.92% |
| Net Income | 39.93% | 49.52% | 40.15% | 34.42% | -22.69% |
| EBIT | -16.13% | -14.86% | -8.01% | -18.85% | 4.59% |
| EBITDA | -7.21% | -9.48% | -5.90% | -15.96% | 3.01% |
| EPS Basic | 37.84% | 45.74% | 36.06% | 29.39% | -26.05% |
| Normalized Basic EPS | -6.80% | -15.52% | -15.90% | -11.43% | -44.31% |
| EPS Diluted | 37.52% | 47.66% | 38.18% | 32.26% | -24.47% |
| Normalized Diluted EPS | -6.86% | -14.81% | -14.81% | -9.82% | -43.04% |
| Average Basic Shares Outstanding | 3.92% | 4.21% | 4.52% | 5.22% | 2.24% |
| Average Diluted Shares Outstanding | 4.04% | 3.77% | 3.54% | 3.68% | -0.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 10.81% | 1.96% | 2.16% | 2.29% | -0.63% |
